Antagonists of protease activated receptor-1 (PAR1)
US7888483B2 · kind B2 · utility
1Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2007 |
| Grant date | Feb 15, 2011 |
| Priority date | — |
| Expiry date | Jul 17, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antibodies or antigen-binding molecules that specifically recognize and antagonize human PAR1 receptor. Also provided in the invention are polynucleotides and vectors that encode such molecules and host cells that harbor the polynucleotides or vectors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.